マラビロックの世界市場（～2026年）

• 英文タイトル：Global Maraviroc (CAS 376348-65-1) Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY07468 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はマラビロックのグローバル市場について調査・分析したレポートです。種類別（純度99％以上、純度99％以下）市場規模、用途別（CCR5拮抗薬、HIV阻害剤）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別マラビロックの競争状況、市場シェア ・世界のマラビロック市場：種類別市場規模 2015年-2020年（純度99％以上、純度99％以下） ・世界のマラビロック市場：種類別市場規模予測 2021年-2026年（純度99％以上、純度99％以下） ・世界のマラビロック市場：用途別市場規模 2015年-2020年（CCR5拮抗薬、HIV阻害剤） ・世界のマラビロック市場：用途別市場規模予測 2021年-2026年（CCR5拮抗薬、HIV阻害剤） ・北米のマラビロック市場分析：米国、カナダ ・ヨーロッパのマラビロック市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのマラビロック市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のマラビロック市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのマラビロック市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Cayman Chemical、Tocris Bioscience、R&D Systems、BOC Sciences ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Maraviroc (CAS 376348-65-1) Market
The global Maraviroc (CAS 376348-65-1) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Maraviroc (CAS 376348-65-1) Scope and Market Size
Maraviroc (CAS 376348-65-1) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Maraviroc (CAS 376348-65-1) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Maraviroc (CAS 376348-65-1) market is segmented into
Purity Above 99%
Purity Below 99%

Segment by Application, the Maraviroc (CAS 376348-65-1) market is segmented into
Antagonist of CCR5
HIV Inhibitors

Regional and Country-level Analysis
The Maraviroc (CAS 376348-65-1) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Maraviroc (CAS 376348-65-1) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Maraviroc (CAS 376348-65-1) Market Share Analysis
Maraviroc (CAS 376348-65-1) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Maraviroc (CAS 376348-65-1) business, the date to enter into the Maraviroc (CAS 376348-65-1) market, Maraviroc (CAS 376348-65-1) product introduction, recent developments, etc.

The major vendors covered:
Cayman Chemical
Tocris Bioscience
R&D Systems
BOC Sciences
…

レポート目次

---

1 Study Coverage
1.1 Maraviroc (CAS 376348-65-1) Product Introduction
1.2 Market Segments
1.3 Key Maraviroc (CAS 376348-65-1) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Maraviroc (CAS 376348-65-1) Market Size Growth Rate by Type
1.4.2 Purity Above 99%
1.4.3 Purity Below 99%
1.5 Market by Application
1.5.1 Global Maraviroc (CAS 376348-65-1) Market Size Growth Rate by Application
1.5.2 Antagonist of CCR5
1.5.3 HIV Inhibitors
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Maraviroc (CAS 376348-65-1) Market Size, Estimates and Forecasts
2.1.1 Global Maraviroc (CAS 376348-65-1) Revenue 2015-2026
2.1.2 Global Maraviroc (CAS 376348-65-1) Sales 2015-2026
2.2 Global Maraviroc (CAS 376348-65-1), Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Maraviroc (CAS 376348-65-1) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Maraviroc (CAS 376348-65-1) Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Maraviroc (CAS 376348-65-1) Competitor Landscape by Players
3.1 Maraviroc (CAS 376348-65-1) Sales by Manufacturers
3.1.1 Maraviroc (CAS 376348-65-1) Sales by Manufacturers (2015-2020)
3.1.2 Maraviroc (CAS 376348-65-1) Sales Market Share by Manufacturers (2015-2020)
3.2 Maraviroc (CAS 376348-65-1) Revenue by Manufacturers
3.2.1 Maraviroc (CAS 376348-65-1) Revenue by Manufacturers (2015-2020)
3.2.2 Maraviroc (CAS 376348-65-1) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Maraviroc (CAS 376348-65-1) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Maraviroc (CAS 376348-65-1) Revenue in 2019
3.2.5 Global Maraviroc (CAS 376348-65-1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Maraviroc (CAS 376348-65-1) Price by Manufacturers
3.4 Maraviroc (CAS 376348-65-1) Manufacturing Base Distribution, Product Types
3.4.1 Maraviroc (CAS 376348-65-1) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Maraviroc (CAS 376348-65-1) Product Type
3.4.3 Date of International Manufacturers Enter into Maraviroc (CAS 376348-65-1) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Maraviroc (CAS 376348-65-1) Market Size by Type (2015-2020)
4.1.1 Global Maraviroc (CAS 376348-65-1) Sales by Type (2015-2020)
4.1.2 Global Maraviroc (CAS 376348-65-1) Revenue by Type (2015-2020)
4.1.3 Maraviroc (CAS 376348-65-1) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Maraviroc (CAS 376348-65-1) Market Size Forecast by Type (2021-2026)
4.2.1 Global Maraviroc (CAS 376348-65-1) Sales Forecast by Type (2021-2026)
4.2.2 Global Maraviroc (CAS 376348-65-1) Revenue Forecast by Type (2021-2026)
4.2.3 Maraviroc (CAS 376348-65-1) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Maraviroc (CAS 376348-65-1) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Maraviroc (CAS 376348-65-1) Market Size by Application (2015-2020)
5.1.1 Global Maraviroc (CAS 376348-65-1) Sales by Application (2015-2020)
5.1.2 Global Maraviroc (CAS 376348-65-1) Revenue by Application (2015-2020)
5.1.3 Maraviroc (CAS 376348-65-1) Price by Application (2015-2020)
5.2 Maraviroc (CAS 376348-65-1) Market Size Forecast by Application (2021-2026)
5.2.1 Global Maraviroc (CAS 376348-65-1) Sales Forecast by Application (2021-2026)
5.2.2 Global Maraviroc (CAS 376348-65-1) Revenue Forecast by Application (2021-2026)
5.2.3 Global Maraviroc (CAS 376348-65-1) Price Forecast by Application (2021-2026)

6 North America
6.1 North America Maraviroc (CAS 376348-65-1) by Country
6.1.1 North America Maraviroc (CAS 376348-65-1) Sales by Country
6.1.2 North America Maraviroc (CAS 376348-65-1) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Maraviroc (CAS 376348-65-1) Market Facts & Figures by Type
6.3 North America Maraviroc (CAS 376348-65-1) Market Facts & Figures by Application

7 Europe
7.1 Europe Maraviroc (CAS 376348-65-1) by Country
7.1.1 Europe Maraviroc (CAS 376348-65-1) Sales by Country
7.1.2 Europe Maraviroc (CAS 376348-65-1) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Maraviroc (CAS 376348-65-1) Market Facts & Figures by Type
7.3 Europe Maraviroc (CAS 376348-65-1) Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Maraviroc (CAS 376348-65-1) by Region
8.1.1 Asia Pacific Maraviroc (CAS 376348-65-1) Sales by Region
8.1.2 Asia Pacific Maraviroc (CAS 376348-65-1) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Maraviroc (CAS 376348-65-1) Market Facts & Figures by Type
8.3 Asia Pacific Maraviroc (CAS 376348-65-1) Market Facts & Figures by Application

9 Latin America
9.1 Latin America Maraviroc (CAS 376348-65-1) by Country
9.1.1 Latin America Maraviroc (CAS 376348-65-1) Sales by Country
9.1.2 Latin America Maraviroc (CAS 376348-65-1) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Maraviroc (CAS 376348-65-1) Market Facts & Figures by Type
9.3 Central & South America Maraviroc (CAS 376348-65-1) Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Maraviroc (CAS 376348-65-1) by Country
10.1.1 Middle East and Africa Maraviroc (CAS 376348-65-1) Sales by Country
10.1.2 Middle East and Africa Maraviroc (CAS 376348-65-1) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Maraviroc (CAS 376348-65-1) Market Facts & Figures by Type
10.3 Middle East and Africa Maraviroc (CAS 376348-65-1) Market Facts & Figures by Application

11 Company Profiles
11.1 Cayman Chemical
11.1.1 Cayman Chemical Corporation Information
11.1.2 Cayman Chemical Description and Business Overview
11.1.3 Cayman Chemical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cayman Chemical Maraviroc (CAS 376348-65-1) Products Offered
11.1.5 Cayman Chemical Related Developments
11.2 Tocris Bioscience
11.2.1 Tocris Bioscience Corporation Information
11.2.2 Tocris Bioscience Description and Business Overview
11.2.3 Tocris Bioscience Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Tocris Bioscience Maraviroc (CAS 376348-65-1) Products Offered
11.2.5 Tocris Bioscience Related Developments
11.3 R&D Systems
11.3.1 R&D Systems Corporation Information
11.3.2 R&D Systems Description and Business Overview
11.3.3 R&D Systems Sales, Revenue and Gross Margin (2015-2020)
11.3.4 R&D Systems Maraviroc (CAS 376348-65-1) Products Offered
11.3.5 R&D Systems Related Developments
11.4 BOC Sciences
11.4.1 BOC Sciences Corporation Information
11.4.2 BOC Sciences Description and Business Overview
11.4.3 BOC Sciences Sales, Revenue and Gross Margin (2015-2020)
11.4.4 BOC Sciences Maraviroc (CAS 376348-65-1) Products Offered
11.4.5 BOC Sciences Related Developments
11.1 Cayman Chemical
11.1.1 Cayman Chemical Corporation Information
11.1.2 Cayman Chemical Description and Business Overview
11.1.3 Cayman Chemical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cayman Chemical Maraviroc (CAS 376348-65-1) Products Offered
11.1.5 Cayman Chemical Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Maraviroc (CAS 376348-65-1) Market Estimates and Projections by Region
12.1.1 Global Maraviroc (CAS 376348-65-1) Sales Forecast by Regions 2021-2026
12.1.2 Global Maraviroc (CAS 376348-65-1) Revenue Forecast by Regions 2021-2026
12.2 North America Maraviroc (CAS 376348-65-1) Market Size Forecast (2021-2026)
12.2.1 North America: Maraviroc (CAS 376348-65-1) Sales Forecast (2021-2026)
12.2.2 North America: Maraviroc (CAS 376348-65-1) Revenue Forecast (2021-2026)
12.2.3 North America: Maraviroc (CAS 376348-65-1) Market Size Forecast by Country (2021-2026)
12.3 Europe Maraviroc (CAS 376348-65-1) Market Size Forecast (2021-2026)
12.3.1 Europe: Maraviroc (CAS 376348-65-1) Sales Forecast (2021-2026)
12.3.2 Europe: Maraviroc (CAS 376348-65-1) Revenue Forecast (2021-2026)
12.3.3 Europe: Maraviroc (CAS 376348-65-1) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Maraviroc (CAS 376348-65-1) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Maraviroc (CAS 376348-65-1) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Maraviroc (CAS 376348-65-1) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Maraviroc (CAS 376348-65-1) Market Size Forecast by Region (2021-2026)
12.5 Latin America Maraviroc (CAS 376348-65-1) Market Size Forecast (2021-2026)
12.5.1 Latin America: Maraviroc (CAS 376348-65-1) Sales Forecast (2021-2026)
12.5.2 Latin America: Maraviroc (CAS 376348-65-1) Revenue Forecast (2021-2026)
12.5.3 Latin America: Maraviroc (CAS 376348-65-1) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Maraviroc (CAS 376348-65-1) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Maraviroc (CAS 376348-65-1) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Maraviroc (CAS 376348-65-1) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Maraviroc (CAS 376348-65-1) Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Maraviroc (CAS 376348-65-1) Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Maraviroc (CAS 376348-65-1) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Maraviroc (CAS 376348-65-1) Market Segments
Table 2. Ranking of Global Top Maraviroc (CAS 376348-65-1) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Maraviroc (CAS 376348-65-1) Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Purity Above 99%
Table 5. Major Manufacturers of Purity Below 99%
Table 6. Global Maraviroc (CAS 376348-65-1) Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Maraviroc (CAS 376348-65-1) Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Maraviroc (CAS 376348-65-1) Sales by Regions 2015-2020 (K MT)
Table 9. Global Maraviroc (CAS 376348-65-1) Sales Market Share by Regions (2015-2020)
Table 10. Global Maraviroc (CAS 376348-65-1) Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Maraviroc (CAS 376348-65-1) Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Maraviroc (CAS 376348-65-1) Sales Share by Manufacturers (2015-2020)
Table 13. Global Maraviroc (CAS 376348-65-1) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Maraviroc (CAS 376348-65-1) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Maraviroc (CAS 376348-65-1) as of 2019)
Table 15. Maraviroc (CAS 376348-65-1) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Maraviroc (CAS 376348-65-1) Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Maraviroc (CAS 376348-65-1) Price (2015-2020) (USD/MT)
Table 18. Maraviroc (CAS 376348-65-1) Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Maraviroc (CAS 376348-65-1) Product Type
Table 20. Date of International Manufacturers Enter into Maraviroc (CAS 376348-65-1) Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Maraviroc (CAS 376348-65-1) Sales by Type (2015-2020) (K MT)
Table 23. Global Maraviroc (CAS 376348-65-1) Sales Share by Type (2015-2020)
Table 24. Global Maraviroc (CAS 376348-65-1) Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Maraviroc (CAS 376348-65-1) Revenue Share by Type (2015-2020)
Table 26. Maraviroc (CAS 376348-65-1) Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Maraviroc (CAS 376348-65-1) Sales by Application (2015-2020) (K MT)
Table 28. Global Maraviroc (CAS 376348-65-1) Sales Share by Application (2015-2020)
Table 29. North America Maraviroc (CAS 376348-65-1) Sales by Country (2015-2020) (K MT)
Table 30. North America Maraviroc (CAS 376348-65-1) Sales Market Share by Country (2015-2020)
Table 31. North America Maraviroc (CAS 376348-65-1) Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Maraviroc (CAS 376348-65-1) Revenue Market Share by Country (2015-2020)
Table 33. North America Maraviroc (CAS 376348-65-1) Sales by Type (2015-2020) (K MT)
Table 34. North America Maraviroc (CAS 376348-65-1) Sales Market Share by Type (2015-2020)
Table 35. North America Maraviroc (CAS 376348-65-1) Sales by Application (2015-2020) (K MT)
Table 36. North America Maraviroc (CAS 376348-65-1) Sales Market Share by Application (2015-2020)
Table 37. Europe Maraviroc (CAS 376348-65-1) Sales by Country (2015-2020) (K MT)
Table 38. Europe Maraviroc (CAS 376348-65-1) Sales Market Share by Country (2015-2020)
Table 39. Europe Maraviroc (CAS 376348-65-1) Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Maraviroc (CAS 376348-65-1) Revenue Market Share by Country (2015-2020)
Table 41. Europe Maraviroc (CAS 376348-65-1) Sales by Type (2015-2020) (K MT)
Table 42. Europe Maraviroc (CAS 376348-65-1) Sales Market Share by Type (2015-2020)
Table 43. Europe Maraviroc (CAS 376348-65-1) Sales by Application (2015-2020) (K MT)
Table 44. Europe Maraviroc (CAS 376348-65-1) Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Maraviroc (CAS 376348-65-1) Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Maraviroc (CAS 376348-65-1) Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Maraviroc (CAS 376348-65-1) Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Maraviroc (CAS 376348-65-1) Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Maraviroc (CAS 376348-65-1) Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Maraviroc (CAS 376348-65-1) Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Maraviroc (CAS 376348-65-1) Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Maraviroc (CAS 376348-65-1) Sales Market Share by Application (2015-2020)
Table 53. Latin America Maraviroc (CAS 376348-65-1) Sales by Country (2015-2020) (K MT)
Table 54. Latin America Maraviroc (CAS 376348-65-1) Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Maraviroc (CAS 376348-65-1) Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Maraviroc (CAS 376348-65-1) Revenue Market Share by Country (2015-2020)
Table 57. Latin America Maraviroc (CAS 376348-65-1) Sales by Type (2015-2020) (K MT)
Table 58. Latin America Maraviroc (CAS 376348-65-1) Sales Market Share by Type (2015-2020)
Table 59. Latin America Maraviroc (CAS 376348-65-1) Sales by Application (2015-2020) (K MT)
Table 60. Latin America Maraviroc (CAS 376348-65-1) Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Maraviroc (CAS 376348-65-1) Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Maraviroc (CAS 376348-65-1) Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Maraviroc (CAS 376348-65-1) Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Maraviroc (CAS 376348-65-1) Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Maraviroc (CAS 376348-65-1) Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Maraviroc (CAS 376348-65-1) Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Maraviroc (CAS 376348-65-1) Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Maraviroc (CAS 376348-65-1) Sales Market Share by Application (2015-2020)
Table 69. Cayman Chemical Corporation Information
Table 70. Cayman Chemical Description and Major Businesses
Table 71. Cayman Chemical Maraviroc (CAS 376348-65-1) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Cayman Chemical Product
Table 73. Cayman Chemical Recent Development
Table 74. Tocris Bioscience Corporation Information
Table 75. Tocris Bioscience Description and Major Businesses
Table 76. Tocris Bioscience Maraviroc (CAS 376348-65-1) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Tocris Bioscience Product
Table 78. Tocris Bioscience Recent Development
Table 79. R&D Systems Corporation Information
Table 80. R&D Systems Description and Major Businesses
Table 81. R&D Systems Maraviroc (CAS 376348-65-1) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. R&D Systems Product
Table 83. R&D Systems Recent Development
Table 84. BOC Sciences Corporation Information
Table 85. BOC Sciences Description and Major Businesses
Table 86. BOC Sciences Maraviroc (CAS 376348-65-1) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. BOC Sciences Product
Table 88. BOC Sciences Recent Development
Table 89. Global Maraviroc (CAS 376348-65-1) Sales Forecast by Regions (2021-2026) (K MT)
Table 90. Global Maraviroc (CAS 376348-65-1) Sales Market Share Forecast by Regions (2021-2026)
Table 91. Global Maraviroc (CAS 376348-65-1) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 92. Global Maraviroc (CAS 376348-65-1) Revenue Market Share Forecast by Regions (2021-2026)
Table 93. North America: Maraviroc (CAS 376348-65-1) Sales Forecast by Country (2021-2026) (K MT)
Table 94. North America: Maraviroc (CAS 376348-65-1) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 95. Europe: Maraviroc (CAS 376348-65-1) Sales Forecast by Country (2021-2026) (K MT)
Table 96. Europe: Maraviroc (CAS 376348-65-1) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 97. Asia Pacific: Maraviroc (CAS 376348-65-1) Sales Forecast by Region (2021-2026) (K MT)
Table 98. Asia Pacific: Maraviroc (CAS 376348-65-1) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 99. Latin America: Maraviroc (CAS 376348-65-1) Sales Forecast by Country (2021-2026) (K MT)
Table 100. Latin America: Maraviroc (CAS 376348-65-1) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 101. Middle East and Africa: Maraviroc (CAS 376348-65-1) Sales Forecast by Country (2021-2026) (K MT)
Table 102. Middle East and Africa: Maraviroc (CAS 376348-65-1) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Market Risks
Table 106. Main Points Interviewed from Key Maraviroc (CAS 376348-65-1) Players
Table 107. Maraviroc (CAS 376348-65-1) Customers List
Table 108. Maraviroc (CAS 376348-65-1) Distributors List
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Maraviroc (CAS 376348-65-1) Product Picture
Figure 2. Global Maraviroc (CAS 376348-65-1) Sales Market Share by Type in 2020 & 2026
Figure 3. Purity Above 99% Product Picture
Figure 4. Purity Below 99% Product Picture
Figure 5. Global Maraviroc (CAS 376348-65-1) Sales Market Share by Application in 2020 & 2026
Figure 6. Antagonist of CCR5
Figure 7. HIV Inhibitors
Figure 8. Maraviroc (CAS 376348-65-1) Report Years Considered
Figure 9. Global Maraviroc (CAS 376348-65-1) Market Size 2015-2026 (US$ Million)
Figure 10. Global Maraviroc (CAS 376348-65-1) Sales 2015-2026 (K MT)
Figure 11. Global Maraviroc (CAS 376348-65-1) Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Maraviroc (CAS 376348-65-1) Sales Market Share by Region (2015-2020)
Figure 13. Global Maraviroc (CAS 376348-65-1) Sales Market Share by Region in 2019
Figure 14. Global Maraviroc (CAS 376348-65-1) Revenue Market Share by Region (2015-2020)
Figure 15. Global Maraviroc (CAS 376348-65-1) Revenue Market Share by Region in 2019
Figure 16. Global Maraviroc (CAS 376348-65-1) Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Maraviroc (CAS 376348-65-1) Revenue in 2019
Figure 18. Maraviroc (CAS 376348-65-1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Maraviroc (CAS 376348-65-1) Sales Market Share by Type (2015-2020)
Figure 20. Global Maraviroc (CAS 376348-65-1) Sales Market Share by Type in 2019
Figure 21. Global Maraviroc (CAS 376348-65-1) Revenue Market Share by Type (2015-2020)
Figure 22. Global Maraviroc (CAS 376348-65-1) Revenue Market Share by Type in 2019
Figure 23. Global Maraviroc (CAS 376348-65-1) Market Share by Price Range (2015-2020)
Figure 24. Global Maraviroc (CAS 376348-65-1) Sales Market Share by Application (2015-2020)
Figure 25. Global Maraviroc (CAS 376348-65-1) Sales Market Share by Application in 2019
Figure 26. Global Maraviroc (CAS 376348-65-1) Revenue Market Share by Application (2015-2020)
Figure 27. Global Maraviroc (CAS 376348-65-1) Revenue Market Share by Application in 2019
Figure 28. North America Maraviroc (CAS 376348-65-1) Sales Growth Rate 2015-2020 (K MT)
Figure 29. North America Maraviroc (CAS 376348-65-1) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Maraviroc (CAS 376348-65-1) Sales Market Share by Country in 2019
Figure 31. North America Maraviroc (CAS 376348-65-1) Revenue Market Share by Country in 2019
Figure 32. U.S. Maraviroc (CAS 376348-65-1) Sales Growth Rate (2015-2020) (K MT)
Figure 33. U.S. Maraviroc (CAS 376348-65-1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Maraviroc (CAS 376348-65-1) Sales Growth Rate (2015-2020) (K MT)
Figure 35. Canada Maraviroc (CAS 376348-65-1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Maraviroc (CAS 376348-65-1) Market Share by Type in 2019
Figure 37. North America Maraviroc (CAS 376348-65-1) Market Share by Application in 2019
Figure 38. Europe Maraviroc (CAS 376348-65-1) Sales Growth Rate 2015-2020 (K MT)
Figure 39. Europe Maraviroc (CAS 376348-65-1) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Maraviroc (CAS 376348-65-1) Sales Market Share by Country in 2019
Figure 41. Europe Maraviroc (CAS 376348-65-1) Revenue Market Share by Country in 2019
Figure 42. Germany Maraviroc (CAS 376348-65-1) Sales Growth Rate (2015-2020) (K MT)
Figure 43. Germany Maraviroc (CAS 376348-65-1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Maraviroc (CAS 376348-65-1) Sales Growth Rate (2015-2020) (K MT)
Figure 45. France Maraviroc (CAS 376348-65-1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Maraviroc (CAS 376348-65-1) Sales Growth Rate (2015-2020) (K MT)
Figure 47. U.K. Maraviroc (CAS 376348-65-1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Maraviroc (CAS 376348-65-1) Sales Growth Rate (2015-2020) (K MT)
Figure 49. Italy Maraviroc (CAS 376348-65-1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Maraviroc (CAS 376348-65-1) Sales Growth Rate (2015-2020) (K MT)
Figure 51. Russia Maraviroc (CAS 376348-65-1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Maraviroc (CAS 376348-65-1) Market Share by Type in 2019
Figure 53. Europe Maraviroc (CAS 376348-65-1) Market Share by Application in 2019
Figure 54. Asia Pacific Maraviroc (CAS 376348-65-1) Sales Growth Rate 2015-2020 (K MT)
Figure 55. Asia Pacific Maraviroc (CAS 376348-65-1) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Maraviroc (CAS 376348-65-1) Sales Market Share by Region in 2019
Figure 57. Asia Pacific Maraviroc (CAS 376348-65-1) Revenue Market Share by Region in 2019
Figure 58. China Maraviroc (CAS 376348-65-1) Sales Growth Rate (2015-2020) (K MT)
Figure 59. China Maraviroc (CAS 376348-65-1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Maraviroc (CAS 376348-65-1) Sales Growth Rate (2015-2020) (K MT)
Figure 61. Japan Maraviroc (CAS 376348-65-1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Maraviroc (CAS 376348-65-1) Sales Growth Rate (2015-2020) (K MT)
Figure 63. South Korea Maraviroc (CAS 376348-65-1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Maraviroc (CAS 376348-65-1) Sales Growth Rate (2015-2020) (K MT)
Figure 65. India Maraviroc (CAS 376348-65-1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Maraviroc (CAS 376348-65-1) Sales Growth Rate (2015-2020) (K MT)
Figure 67. Australia Maraviroc (CAS 376348-65-1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Maraviroc (CAS 376348-65-1) Sales Growth Rate (2015-2020) (K MT)
Figure 69. Taiwan Maraviroc (CAS 376348-65-1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Maraviroc (CAS 376348-65-1) Sales Growth Rate (2015-2020) (K MT)
Figure 71. Indonesia Maraviroc (CAS 376348-65-1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Maraviroc (CAS 376348-65-1) Sales Growth Rate (2015-2020) (K MT)
Figure 73. Thailand Maraviroc (CAS 376348-65-1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Maraviroc (CAS 376348-65-1) Sales Growth Rate (2015-2020) (K MT)
Figure 75. Malaysia Maraviroc (CAS 376348-65-1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Maraviroc (CAS 376348-65-1) Sales Growth Rate (2015-2020) (K MT)
Figure 77. Philippines Maraviroc (CAS 376348-65-1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Maraviroc (CAS 376348-65-1) Sales Growth Rate (2015-2020) (K MT)
Figure 79. Vietnam Maraviroc (CAS 376348-65-1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Maraviroc (CAS 376348-65-1) Market Share by Type in 2019
Figure 81. Asia Pacific Maraviroc (CAS 376348-65-1) Market Share by Application in 2019
Figure 82. Latin America Maraviroc (CAS 376348-65-1) Sales Growth Rate 2015-2020 (K MT)
Figure 83. Latin America Maraviroc (CAS 376348-65-1) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Maraviroc (CAS 376348-65-1) Sales Market Share by Country in 2019
Figure 85. Latin America Maraviroc (CAS 376348-65-1) Revenue Market Share by Country in 2019
Figure 86. Mexico Maraviroc (CAS 376348-65-1) Sales Growth Rate (2015-2020) (K MT)
Figure 87. Mexico Maraviroc (CAS 376348-65-1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Maraviroc (CAS 376348-65-1) Sales Growth Rate (2015-2020) (K MT)
Figure 89. Brazil Maraviroc (CAS 376348-65-1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Maraviroc (CAS 376348-65-1) Sales Growth Rate (2015-2020) (K MT)
Figure 91. Argentina Maraviroc (CAS 376348-65-1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Maraviroc (CAS 376348-65-1) Market Share by Type in 2019
Figure 93. Latin America Maraviroc (CAS 376348-65-1) Market Share by Application in 2019
Figure 94. Middle East and Africa Maraviroc (CAS 376348-65-1) Sales Growth Rate 2015-2020 (K MT)
Figure 95. Middle East and Africa Maraviroc (CAS 376348-65-1) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Maraviroc (CAS 376348-65-1) Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Maraviroc (CAS 376348-65-1) Revenue Market Share by Country in 2019
Figure 98. Turkey Maraviroc (CAS 376348-65-1) Sales Growth Rate (2015-2020) (K MT)
Figure 99. Turkey Maraviroc (CAS 376348-65-1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Maraviroc (CAS 376348-65-1) Sales Growth Rate (2015-2020) (K MT)
Figure 101. Saudi Arabia Maraviroc (CAS 376348-65-1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Maraviroc (CAS 376348-65-1) Sales Growth Rate (2015-2020) (K MT)
Figure 103. U.A.E Maraviroc (CAS 376348-65-1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Maraviroc (CAS 376348-65-1) Market Share by Type in 2019
Figure 105. Middle East and Africa Maraviroc (CAS 376348-65-1) Market Share by Application in 2019
Figure 106. North America Maraviroc (CAS 376348-65-1) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 107. North America Maraviroc (CAS 376348-65-1) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Maraviroc (CAS 376348-65-1) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. Europe Maraviroc (CAS 376348-65-1) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Maraviroc (CAS 376348-65-1) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Asia Pacific Maraviroc (CAS 376348-65-1) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Maraviroc (CAS 376348-65-1) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Latin America Maraviroc (CAS 376348-65-1) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Maraviroc (CAS 376348-65-1) Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Middle East and Africa Maraviroc (CAS 376348-65-1) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed

---